Atlas Trials

PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

Clinical trial NCT02608242 · TERMINATED

Trial details

NCT number
NCT02608242
Sponsor
Yuhan Corporation
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
HypertensionHyperlipidemia
Start date
2015-11-01
Primary completion
2016-06-01
Enrollment
123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.